GH Research is trading at approximately $25.00, down 6% today as the stock pulls back following a significant year-to-date rally.
- The decline is driven by a broader biotech sector selloff and lingering pressure from a larger-than-expected Q1 loss, which resulted in several analyst price-target cuts.
- Investors are taking profits following a sharp run-up previously fueled by positive depression trial data and bullish analyst coverage.